Device Trial Radar · NCT06546046
Analysis of the Efficacy and Stability of a Wearable ECG Monitor
Last checked: Nov 20, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 9, 2024
Primary completion
Dec 30, 2024
Study completion Mar 30, 2025
Sponsor
- Lead sponsor
- Mezoo Co., Ltd.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 9, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring
Conditions
- Arrhythmias, Cardiac
- Bradycardia
- Tachycardia
- Atrial Fibrillation
- Atrial Flutter
- Ventricular Premature Complexes
Interventions
ECG monitoring by telemetry device and patch-type ECG monitor at the same timeDevice
The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of total QRS complexTime frame: Within 3 months after electrocardiogram monitoring procedure
- The rate of signal lossTime frame: Within 3 months after electrocardiogram monitoring procedure
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.